WS
The startup develops immunotherapy targeting cancer stem cells to enhance the immune microenvironment, facilitating the creation of small-molecule drugs for tumor treatment. Their approach addresses the challenge of ineffective cancer therapies by providing more effective and targeted treatment options.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops immunotherapy targeting cancer stem cells to enhance the immune microenvironment, facilitating the creation of small-molecule drugs for tumor treatment. Their approach addresses the challenge of ineffective cancer therapies by providing more effective and targeted treatment options.